NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000002367

Registered date:21/08/2009

Efficacy of the additional effect of LTRA to the asthmatics who has taken both ICS and LABA.

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedbronchial asthma
Date of first enrollment2009/09/01
Target sample size50
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)inhalation corticosteroid + long-acting beta-2 agonist as treatment continues for eight weeks. 10mg of montelukast sodium added for inhalation corticosteroid + long-acting beta-2 agonist as treatment and it continues for eight weeks.

Outcome(s)

Primary OutcomeAmount of change of ACT number (for four weeks)
Secondary Outcome

Key inclusion & exclusion criteria

Age minimumNot applicable
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteria1)Patient who has previous history of side effect or hypersensitivity serious compared with element of research medicine 2)Patient judged to be improper according to doctor when targeting it

Related Information

Contact

public contact
Name
Address 377-02 Ohnohigashi, Osaka-sayama, Osaka 589-0014,Japan. Japan
Telephone 072-366-0221
E-mail iwanaga@med.kindai.ac.jp
Affiliation Graduate School of Medicine Kinki University Department of Respiratory Medicine and Allegology
scientific contact
Name Yuji Tohda
Address 377-02 Ohnohigashi, Osaka-sayama, Osaka 589-0014,Japan. Japan
Telephone
E-mail
Affiliation Graduate School of Medicine Kinki University Department of Respiratory Medicine and Allegology